Understanding Hair Loss
Ozempic, Mounjaro and Hair Loss: Why It Happens and What to Do
GLP-1 drugs like Ozempic, Wegovy and Mounjaro are linked to hair loss. What the studies show, why it happens, whether it grows back and what to do.
Started Ozempic, Wegovy, Mounjaro or Zepbound and now you’re finding more hair in the shower? You’re not imagining it, and you’re not alone. Hair loss is a recognized side effect of GLP-1 weight-loss drugs.
Short answer: GLP-1 drugs are linked to a roughly threefold higher risk of hair loss than placebo, but it still affects a small minority of users (about 4 in 100 in clinical trials). In most cases it looks like temporary shedding triggered by rapid weight loss, which usually settles once your weight stabilizes. Don’t stop your medication on your own: talk to your prescriber first.
How common is it?
The best numbers come from a 2026 meta-analysis that pooled nine clinical studies (seven of them randomized controlled trials) with 4,114 people taking GLP-1 drugs:
- People on GLP-1 drugs were about 3.3 times more likely to report hair loss than people on placebo.
- The risk was similar (about 3.6 times) when the analysis looked only at trials in people with overweight or obesity.
- Overall, about 3.9% of users reported hair loss.
So the risk is real, but most people taking these drugs don’t notice any hair loss at all.
Which drugs are most linked to it?
A 2026 systematic review of 24 studies found that:
- Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) had the highest rates of hair loss and showed up most often in drug-safety reports.
- Hair loss with semaglutide seemed dose-dependent: it was rarely reported at the lower doses used for diabetes, and more often at the higher doses used for weight loss.
- Tirzepatide, which causes the most weight loss, was the drug most often linked to telogen effluvium.
- Older GLP-1 drugs (liraglutide, dulaglutide, exenatide) were studied less and generally showed a lower risk.
- Women appeared to be affected more often than men.
Why does it happen?
Nobody has proven exactly why yet. A 2026 review by hair specialists points out that most of the evidence comes from drug-safety databases and retrospective studies, and that causality hasn’t been established. Their leading explanation is the speed of the weight loss itself.
Losing a lot of weight quickly is a shock to the body, and it can push a large number of hair follicles into their resting phase at the same time. A few months later those hairs fall out together. This is called telogen effluvium, and it’s the same thing that can happen after surgery, a high fever, a crash diet or a very stressful period. Shedding typically starts two to three months after the trigger, which is why many people notice it a few months into treatment, not in the first weeks.
For men there’s a second possibility worth knowing about: the reviews also found pattern hair loss (androgenetic alopecia) among the reported cases. If you were already genetically prone to balding, a period of heavy shedding can make thinning more noticeable or seem to speed it up.
Will it grow back?
If it’s telogen effluvium, the outlook is good. The follicles aren’t damaged, and acute telogen effluvium usually stops on its own within about six months once the trigger has passed. For most people that means once their weight loss slows down and stabilizes. Regrowth then takes several more months to become visible, because hair only grows about a centimeter a month.
If shedding goes on for more than six months, or you notice a receding hairline or a thinning crown rather than thinning all over, it’s worth seeing a dermatologist to check for pattern hair loss, which doesn’t recover on its own.
What you can do
- Don’t stop your medication without talking to your prescriber. For most people the health benefits of the drug matter more than temporary shedding, and your prescriber can weigh that with you.
- Ask about the pace of your weight loss. Since rapid weight loss is the main suspect, your prescriber may be able to adjust your dose or titration.
- Eat enough, especially protein. GLP-1 drugs reduce appetite a lot. Very low intake is itself a classic trigger for shedding, so ask your doctor or a dietitian whether your diet covers what you need.
- Track it. Take photos of your hairline and crown in the same light each month, so you can see whether things are settling or getting worse.
- See a dermatologist if shedding lasts more than six months or looks like pattern hair loss. Proven treatments such as minoxidil are an option they may discuss.
The bottom line
Hair loss on Ozempic, Wegovy or Mounjaro is real but uncommon, and most cases look like temporary shedding from fast weight loss rather than permanent damage. Give it time, keep your prescriber in the loop, and get checked if it doesn’t settle within six months.
Sources
- Glucagon-like peptide-1 receptor agonists and hair loss: A systematic review and meta-analysis (Meta-analysis, Diabetes Research and Clinical Practice, 2026)
- GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling (Review, Science Progress, 2026)
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes (Review, Dermatology and Therapy, 2026)
- Telogen Effluvium: A Review of the Literature (Review, Cureus, 2020)
This article is for education only and is not medical advice. Talk to a doctor or dermatologist before starting or changing any treatment. Medical disclaimer